| 1 |
PDCD1
💬
| 3件: Cell adhesion molecule (CAM) interaction Cell adhesion molecule (CAM) interaction, T cell receptor signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer | Nivolumab
Nivolumab
💬
|
Nivolumab
| 12件: 13 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬
|
| 2 |
PDCD1
💬
| 3件: Cell adhesion molecule (CAM) interaction Cell adhesion molecule (CAM) interaction, T cell receptor signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer | Peresolimab
Peresolimab
💬
|
Peresolimab
| 1件: 46 46 💬
|
| 3 |
PDCD1
💬
| 3件: Cell adhesion molecule (CAM) interaction Cell adhesion molecule (CAM) interaction, T cell receptor signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer | Pembrolizumab
Pembrolizumab
💬
|
Pembrolizumab
| 3件: 25 25, 97, 285 💬
|
| 4 |
PDCD1
💬
| 3件: Cell adhesion molecule (CAM) interaction Cell adhesion molecule (CAM) interaction, T cell receptor signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer | Retifanlimab
Retifanlimab
💬
|
Retifanlimab
| 1件: 34 34 💬
|
| 5 |
PDCD1
💬
| 3件: Cell adhesion molecule (CAM) interaction Cell adhesion molecule (CAM) interaction, T cell receptor signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer | Rosnilimab
Rosnilimab
💬
|
Rosnilimab
| 2件: 46 46, 97 💬
|